Cargando…
Cis- and trans-regulations of pre-mRNA splicing by RNA editing enzymes influence cancer development
RNA editing and splicing are the two major processes that dynamically regulate human transcriptome diversity. Despite growing evidence of crosstalk between RNA editing enzymes (mainly ADAR1) and splicing machineries, detailed mechanistic explanations and their biological importance in diseases, such...
Autores principales: | Tang, Sze Jing, Shen, Haoqing, An, Omer, Hong, HuiQi, Li, Jia, Song, Yangyang, Han, Jian, Tay, Daryl Jin Tai, Ng, Vanessa Hui En, Bellido Molias, Fernando, Leong, Ka Wai, Pitcheshwar, Priyankaa, Yang, Henry, Chen, Leilei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005744/ https://www.ncbi.nlm.nih.gov/pubmed/32034135 http://dx.doi.org/10.1038/s41467-020-14621-5 |
Ejemplares similares
-
Suppression of adenosine-to-inosine (A-to-I) RNA editome by death associated protein 3 (DAP3) promotes cancer progression
por: Han, Jian, et al.
Publicado: (2020) -
ADARs act as potent regulators of circular transcriptome in cancer
por: Shen, Haoqing, et al.
Publicado: (2022) -
Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer
por: Hong, HuiQi, et al.
Publicado: (2018) -
Multilayered control of splicing regulatory networks by DAP3 leads to widespread alternative splicing changes in cancer
por: Han, Jian, et al.
Publicado: (2022) -
An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer
por: Qi, Lihua, et al.
Publicado: (2017)